PCI Biotech Holding Balance Sheet Health
Financial Health criteria checks 6/6
PCI Biotech Holding has a total shareholder equity of NOK39.0M and total debt of NOK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NOK44.1M and NOK5.0M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
| Interest coverage ratio | n/a |
| Cash | kr41.18m |
| Equity | kr39.04m |
| Total liabilities | kr5.01m |
| Total assets | kr44.05m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4QG's short term assets (NOK43.8M) exceed its short term liabilities (NOK5.0M).
Long Term Liabilities: 4QG's short term assets (NOK43.8M) exceed its long term liabilities (NOK34.0K).
Debt to Equity History and Analysis
Debt Level: 4QG is debt free.
Reducing Debt: 4QG has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4QG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 4QG has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 0.6% each year.